₃Claudia Sissi

Summary for 2004 [at-glance overview of Claudia Sissi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Claudia Sissi. According to available data, in 2004 Claudia Sissi published at least 3 articles. This work was completed in collaboration with several authors including Palumbo, Manlio and Moro, Stefano. Many other authors have collaborated with Claudia Sissi as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that Claudia Sissi professional interests are focused around "antitumor potential aza-bioisosterism", "efficient zn ii" and "studies 9-aza regioisomers". These might also be referred to as "zn ii", "ii based" or "biochemical studies". Statistical analysis shows that Claudia Sissi's writing is likely to contains terms "dna", "ii", "drugs", "properties", "different" and "complex".

The majority of Claudia Sissi articles are affiliated with Department of Pharmaceutical Sciences, University of Padova, Via Marzolo, 5, 35131 Padova, Italy. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Claudia Sissi]

Do you know Claudia Sissi who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Claudia Sissi]

₁₅Sissi, C

Year 2004 Charts [Claudia Sissi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Claudia Sissi publication and funding history for the range of years]

Emails (1) [email addresses extracted from Claudia Sissi affiliations]

hidden to prevent spam, click here to reveal

Claudia Sissi Coauthors (11) [all coauthors with the number of joint publications]

3

2

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (2) [condensed summary of the Claudia Sissi affiliations, the leading number and the color conveys importance]

₂Department of Pharmaceutical Sciences, University of Padova, Via Marzolo, 5, 35131 Padova, Italy.
₁Dipartimento di Scienze Chimiche e Istituto CNR Tecnologia delle Membrane-Sezione di Padova, Università di Padova, via Marzolo 1, I-35131 Padua, Italy.

Key Opinion Leader In [Claudia Sissi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (20) [keywords assigned to Claudia Sissi articles by PubMed, the leading number and the color conveys importance]

₂Anthraquinones | ₂Humans | ₂Models, Molecular | ₂Intercalating Agents | ₁Cyclohexanes | ₁Organometallic Compounds | ₁Esters | ₁Zinc | ₁Animals | ₁Deoxyribonucleases | ₁Binding Sites | ₁Antineoplastic Agents | ₁Biomimetic Materials | ₁DNA | ₁Tumor Cells, Cultured | ₁DNA Topoisomerases, Type II | ₁Anthracyclines | ₁Plasmids | ₁Aza Compounds | ₁Neoplasms

Claudia Sissi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Claudia Sissi might be a good expert witness on these terms]

₈dna | ₆ii | ₆drugs | ₄properties | ₄different | ₄complex | ₄antitumor | ₄anticancer | ₄regioisomers | ₄cleavage | ₄group | ₄9-aza | ₃spacer | ₃activity | ₃affinity | ₃potential | ₃zn | ₃length | ₃molecular | ₂aza-anthrapyrazoles | ₂families | ₂topoisomerase | ₂efficient | ₂biochemical | ₂isoforms | ₂trials | ₂linked | ₂toward | ₂carbocyclic | ₂studies | ₂based | ₂clinical
₃zn ii | ₂ii based | ₂biochemical studies | ₂clinical trials | ₂aza-bioisosterism anthracenedione-based | ₂antitumor potential | ₂aza-anthrapyrazoles biophysical | ₂biophysical biochemical | ₂efficient zn | ₂physico-chemical properties | ₂anthracenedione-based drugs | ₂potential aza-bioisosterism | ₂affinity specificity | ₂9-aza regioisomers | ₂artificial nucleases | ₂based artificial | ₂toward efficient | ₂topoisomerase ii | ₂antitumor aza-anthrapyrazoles | ₂studies 9-aza | ₂anthraquinone group | ₂drugs antitumor | ₁nitrogens carbocyclic | ₁changes physico-chemical | ₁basis dramatically | ₁microm complex | ₁complex derivative | ₁lipophilicity protonation | ₁trials appear | ₁activity isoforms | ₁view approval | ₁tropism solid
₂antitumor potential aza-bioisosterism | ₂efficient zn ii | ₂studies 9-aza regioisomers | ₂biochemical studies 9-aza | ₂aza-anthrapyrazoles biophysical biochemical | ₂toward efficient zn | ₂zn ii based | ₂based artificial nucleases | ₂biophysical biochemical studies | ₂antitumor aza-anthrapyrazoles biophysical | ₂ii based artificial | ₂aza-bioisosterism anthracenedione-based drugs | ₂potential aza-bioisosterism anthracenedione-based | ₁corresponding members 9-aza | ₁dna binding properties | ₁efficiency length spacer | ₁shape electronic distribution | ₁comparing 8-substituted congeners | ₁different aza-ap regioisomers | ₁anthraquinone lacking zn-triaminocyclohexane | ₁intercalator conjugates designed | ₁possible gain insight | ₁comprises triaminocyclohexane platform | ₁targets dna dna-topoisomerase | ₁cleavage complex studied | ₁system parent drugs | ₁spacer induces hydrolytic | ₁electronic distribution redox | ₁view approval anticancer | ₁nucleases ligand structure | ₁comparison reactivity different | ₁aza-bioisosteres anthrapyrazoles aza-aps

Reader's Comments (0) [comments posted by readers of Claudia Sissi profile]